Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lyra Therapeutics, Inc. | Chief Technology Officer | Stock Options | 200K | Jan 30, 2024 | Direct | ||
Forma Therapeutics Holdings, Inc. | SVP, Chief Technology Officer | Common Stock | 0 | $5.05 | Oct 14, 2022 | Direct | |
Forma Therapeutics Holdings, Inc. | SVP, Chief Technology Officer | Stock Option (Right to Buy) | 0 | Oct 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LYRA | Lyra Therapeutics, Inc. | Jan 30, 2024 | 1 | $0 | 4 | Feb 1, 2024 | Chief Technology Officer |
LYRA | Lyra Therapeutics, Inc. | Feb 27, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Technology Officer |
LYRA | Lyra Therapeutics, Inc. | Feb 27, 2023 | 0 | $0 | 3 | Feb 28, 2023 | Chief Technology Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Oct 14, 2022 | 3 | $0 | 4 | Oct 14, 2022 | SVP, Chief Technology Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Feb 28, 2022 | 2 | $0 | 4 | Mar 2, 2022 | SVP, Chief Technology Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Jun 14, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Chief Technology Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Jun 14, 2021 | 0 | $0 | 3 | Jun 15, 2021 | Chief Technology Officer |